FLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS Tumor

NCT00660582 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

152

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Cetuximab (Erbitux)
DRUG: Oxaliplatin (Eloxatin) + Fluorouracil + folinic acid

Sponsor

Per Pfeiffer

Collaborators

[object Object]